Blood test may predict heart device success
NCT ID NCT07469137
First seen Mar 14, 2026 · Last updated May 07, 2026 · Updated 5 times
Summary
This study looks at whether a substance called YKL-40 in the blood can help predict how well heart failure patients will respond to a special pacemaker treatment called cardiac resynchronization therapy (CRT). About 51 patients will give blood samples during their routine CRT procedure and be checked 6 months later. The goal is to find a simple way to know ahead of time who will benefit most from CRT.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC RESYNCHRONISATION THERAPY (CRT) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Trakya University
Edirne, Edirne, Turkey (Türkiye)
Conditions
Explore the condition pages connected to this study.